Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole for prevention of early OHSS in PCOS patients undergoing IVF
IRCT20220522054961N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ovarian hyperstimulation syndrome (OHSS) comparing Letrozole with Placebo (2 arms). Primary endpoints: OHSS level and Serum estrogen level. Started May 2026; status: completed.
02
Drugs
letrozole
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on IRCT20220522054961N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220522054961N2.